首页> 美国卫生研究院文献>Scientific Reports >Screening of SOD1 FUS and TARDBP genes in patients with amyotrophic lateral sclerosis in central-southern China
【2h】

Screening of SOD1 FUS and TARDBP genes in patients with amyotrophic lateral sclerosis in central-southern China

机译:中南部地区肌萎缩性侧索硬化患者SOD1FUS和TARDBP基因的筛选

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease affecting motor neurons of the brain, brainstem and spinal cord. To date, mutations in more than 30 genes have been linked to the pathogenesis of ALS. Among them, SOD1, FUS and TARDBP are ranked as the three most common genes associated with ALS. However, no mutation analysis has been reported in central-southern China. In this study, we sequenced SOD1, FUS and TARDBP in a central-southern Chinese cohort of 173 patients with ALS (15 familial ALS and 158 sporadic ALS) to detect mutations. As a result, five missense mutations in SOD1, namely, p.D101N, p.D101G, p.C111Y, p.N86S and p.V87A, were identified in three unrelated familial probands and three sporadic cases; two mutations in FUS were found in two unrelated familial probands, including an insertion mutation (p.P525_Y526insY) and a missense mutation (p.R521H); no variants of TARDBP were observed in patients. Therefore, SOD1 mutations were present in 20.0% of familial ALS patients and 1.9% of sporadic ALS patients, while FUS mutations were responsible for 13.3% of familial ALS cases, and TARDBP mutations were rare in either familial or sporadic ALS cases. This study broadens the known mutational spectrum in patients with ALS and further demonstrates the necessity for genetic screening in ALS patients from central-southern China.
机译:肌萎缩性侧索硬化症(ALS)是一种致命的神经退行性疾病,会影响大脑,脑干和脊髓的运动神经元。迄今为止,已有30多个基因的突变与ALS的发病机理有关。其中,SOD1,FUS和TARDBP被列为与ALS相关的三个最常见的基因。但是,中南部地区尚无突变分析的报道。在这项研究中,我们对173名ALS患者(15例家族性ALS和158例散发性ALS)的中南部队列研究了SOD1,FUS和TARDBP的序列,以检测突变。结果,在三个无关家族先证者和三个散发病例中,发现了SOD1的五个错义突变,即p.D101N,p.D101G,p.C111Y,p.N86S和p.V87A。在两个不相关的家族先证者中发现了FUS的两个突变,包括插入突变(p.P525_Y526insY)和错义突变(p.R521H);在患者中未观察到TARDBP的变异。因此,家族性ALS患者中20.0%和散发性ALS患者中有1.9%存在SOD1突变,而家族性ALS患者中FUS突变占13.3%,而家族性或散发性ALS患者中TARDBP突变很少见。这项研究拓宽了ALS患者的已知突变谱,并进一步证明了对中南部中国ALS患者进行基因筛查的必要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号